Neurodegeneration
Neurodegenerative Diseases
Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including ALS, Parkinson’s, Alzheimer’s, and Huntington’s – occur as a result of neurodegenerative processes.
Mental health, cognition, emotion, and other processes seated in the brain are regulated by cannabis-sensitive receptors.
Article
A neuroscientist challenges the central fallacy of Reefer Madness
Article
An excerpt adapted from The Rebel's Apothecary: A Practical Guide to the Healing Magic of Cannabis, CBD, and Mushrooms.
Book Excerpt
Cannabis therapeutics for the elderly are featured at the IACM conference in Berlin, Germany.
Article
Brazilian researchers looked into CBD's health effects in an animal model of diabetic brain damage due to oxygen deprivation and found promising results.
Quick Hit
One broad effect of CBD and THC is the stimulation of neurogenesis — the production and integration of new neurons in the brain.
Quick Hit
Scientists employed by the US government filed a patent in 2001 for cannabinoids as antioxidants and neuroprotectants, citing their potential for treating Alzheimer’s disease among others.
Quick Hit
A pilot study recently demonstrated that cannabis extracts can be safely used to ameliorate symptoms of severe dementia.
Quick Hit
Most everyone has bit into a spicy pepper and felt heat permeate their mouth. This feeling comes from activation of TRPV1 receptors.
Quick Hit
THC and other cannabinoids are known to induce neurogenesis — the creation of new neurons — in the brain.
Quick Hit
Science abstracts on CBD and Neurodegeneration
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease
- Cannabinoids: Novel medicines for the treatment of Huntington’s disease
- Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors
- Controlled clinical trial of cannabidiol in Huntington’s disease
- Prospects for cannabinoid therapies in basal ganglia disorders
- Neuroprotective properties of cannabigerol in Huntington’s Disease: Studies in R6/2 mice and 3-nitropropionate-lesioned mice
- Effects of a Sativex-like combination of phytocannabinoids on disease progression in R6/2 mice, an experimental model of Huntington's Disease
- Neurological aspects of medical use of CBD
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- CBD activates neuronal precursor genes in human gingival mesenchymal stromal cells
- Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid
These links are from third-party sites and are provided as a courtesy to the reader.
Cannabis Conversations
Top Stories
THE ESSENTIAL GUIDE TO CBD
By the Editors of Reader’s Digest & Project CBD: Everything You Need to Know About What It Helps, Where to Buy It, and How to Take It.